Epidemiology and Clinical Features of Guillain-Barre Syndrome in Isfahan, Iran

Ansari, Behnaz; Basiri, Keivan; Derakhshan, Yeganeh; Kadkhodaei, Farzaneh; Okhovat, Ali Asghar

Epidemiology and Clinical Features of Guillain-Barre Syndrome in Isfahan, Iran

Document Type : Original Article

Authors

¹ Isfahan Neurosciences Research Center, Alzahra Research Institute; Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran

² Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Iran

³ Sina Trauma and Surgery Research Center; Department of Neurology, Tehran University of Medical Sciences, Sina Hospital, Tehran, Iran

Abstract

Background: Guillain-Barre syndrome (GBS) is an immune-mediated peripheral neuropathy. We compared clinical, laboratory characteristics, and disease course of GBS subtypes in a large group of Iranian patients in Isfahan. Materials and Methods: We collected data from patients who were admitted to Alzahra referral university Hospital, Isfahan, Iran with a diagnosis of GBS. In this population-based cross-sectional research, characteristic of 388 cases with GBS between 2010 and 2015 were studied. Results: The current study recruited 388 patients with GBS including 241 males (62.1%) and 147 females (37.9%) with a mean age of 42.78 ± 21.34. Patients with polyradiculopathy had the highest mean age of 55.12 ± 20.59 years, whereas the least age was seen in acute motor axonal neuropathy (AMAN) with the mean of 36.30 ± 18.71 years. The frequency of GBS witnessed the highest frequency in spring with 113 cases (29.1%) and winter with 101 cases (26%). Patients' electrodiagnostic findings indicated that the highest frequency pertained to AMSAN with 93 cases (24%), whereas the least frequent diagnosis was acute Polyradiculopathy with 8 cases (2.1%). Most of the patients did not have any infections (53.6%) and among patients with infections, AMSAN had the highest frequency (22.9%) and finally, patients with AMSAN and AMAN had a higher length of stay. Conclusion: The study demonstrated incidence, sex distribution, preceding infection, and surgery similar to previous studies. However, our data differs from a study in Tehran that showed acute inflammatory demyelinating polyradiculoneuropathy is more prevalent than other types and we found a seasonal preponderance in cold months, particularly in axonal types.

Keywords

References

1.	Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997;176 Suppl 2:S92-8. [PUBMED]
2.	Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain Barre syndrome. Ann Neurol 1978;3:565-6.
3.	Govoni V, Granieri E. Epidemiology of the Guillain-Barre syndrome. Curr Opin Neurol 2001;14:605-13. [PUBMED]
4.	Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294. [PUBMED]
5.	Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: A systematic review and meta-analysis. Neuroepidemiology 2011;36:123-33. [PUBMED]
6.	Morris AM, Elliott EJ, D'Souza RM, Antony J, Kennett M, Longbottom H, et al. Acute flaccid paralysis in Australian children. J Paediatr Child Health 2003;39:22-6.
7.	Carroll JE, Jedziniak M, Guggenheim MA. Guillain-Barré syndrome. Another cause of the “floppy infant”. Am J Dis Child 1977;131:699-700. [PUBMED]
8.	Buchwald B, de Baets M, Luijckx GJ, Toyka KV. Neonatal Guillain-Barré syndrome: Blocking antibodies transmitted from mother to child. Neurology 1999;53:1246-53. [PUBMED]
9.	Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-66. [PUBMED]
10.	Burns TM. Guillain-Barré syndrome. Semin Neurol 2008;28:152-67. [PUBMED]
11.	Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27:S21-4. [PUBMED]
12.	Kleyweg RP, Van der Meche FG. Treatment related fluctuations in Guillain Barré syndrome after high dose immunoglobulins or plasma exchange. J Neurol Neurosurg Psychiatry 1991;54:957-60.
13.	Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT. Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2012;78:1009-15. [PUBMED]
14.	Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 2014;137:33-43.
15.	Frankle RT. Nutrition education in the medical school curriculum: A proposal for action: A curriculum design. Am J Clin Nutr 1976;29:105-9. [PUBMED]
16.	Dourado ME, Félix RH, da Silva WK, Queiroz JW, Jeronimo SM. Clinical characteristics of Guillain-Barré syndrome in a tropical country: A Brazilian experience. Acta Neurol Scand 2012;125:47-53.
17.	Blaser MJ, Olivares A, Taylor DN, Cornblath DR, McKhann GM. Campylobacter serology in patients with Chinese paralytic syndrome. Lancet 1991;338:308.
18.	Verity C, Stellitano L, Winstone AM, Andrews N, Stowe J, Miller E, et al. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children. Lancet 2011;378:1545-6.
19.	Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F, et al. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: Population based cohort study in Stockholm, Sweden. BMJ 2011;343:d5956.
20.	Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, et al. H1N1 and seasonal influenza vaccine safety in the vaccine safety Datalink project. Am J Prev Med 2011;41:121-8. [PUBMED]
21.	Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study. Lancet 2016;387:1531-9.
22.	Nelson L, Gormley R, Riddle MS, Tribble DR, Porter CK. The epidemiology of Guillain-Barré syndrome in U.S. military personnel: A case-control study. BMC Res Notes 2009;2:171.
23.	Hui AC, Chow KM, Tang AS, Fu M, Kay R, Wong KS, et al. Electrophysiological, clinical and epidemiological study of Guillain-Barre syndrome in Hong Kong Chinese. J Clin Neurosci 2005;12:134-6.
24.	Bahou YG, Biary N, al Deeb S. Guillain-Barre syndrome: A series observed at Riyadh armed forces hospital January 1984 – January 1994. J Neurol 1996;243:147-52. [PUBMED]
25.	Lin JJ, Hsia SH, Wang HS, Lyu RK, Chou ML, Hung PC, et al. Clinical variants of Guillain-Barré syndrome in children. Pediatr Neurol 2012;47:91-6. [PUBMED]
26.	Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome: Clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998;44:780-8. [PUBMED]
27.	Nagarajan V, Al-Shubaili A. Clinical and neurophysiological pattern of Guillain-Barré syndrome in Kuwait. Med Princ Pract 2006;15:120-5. [PUBMED]
28.	Shafqat S, Khealani BA, Awan F, Abedin SE. Guillain-Barré syndrome in Pakistan: Similarity of demyelinating and axonal variants. Eur J Neurol 2006;13:662-5. [PUBMED]
29.	Gupta D, Nair M, Baheti NN, Sarma PS, Kuruvilla A, Diplomate-American Board, et al. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: An analysis of 142 cases. J Clin Neuromuscul Dis 2008;10:42-51.
30.	Yadegari S, Kazemi N, Nafissi S. Clinical and electrophysiological features of Guillain-Barré syndrome in Iran. J Clin Neurosci 2014;21:1554-7. [PUBMED]
31.	Nagasawa K, Kuwabara S, Misawa S, Fujii K, Tanabe Y, Yuki N, et al. Electrophysiological subtypes and prognosis of childhood Guillain-Barré Syndrome in Japan. Muscle Nerve 2006;33:766-70. [PUBMED]
32.	Ropper AH, Shahani BT. Pain in Guillain-Barré syndrome. Arch Neurol 1984;41:511-4. [PUBMED]
33.	Hao Q, Saida T, Yoshino H, Kuroki S, Nukina M, Saida K, et al. Anti-galNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance. Ann Neurol 1999;45:758-68.
34.	Nachamkin I, Allos BM, Ho T. Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev 1998;11:555-67. [PUBMED]

Advanced Biomedical Research